We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.36B
AUM Growth
+$1.18B
Cap. Flow
+$206M
Cap. Flow %
4.73%
Top 10 Hldgs %
59.63%
Holding
58
New
13
Increased
19
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$59.8M
2
ELV icon
Elevance Health
ELV
+$56.6M
3
LYFT icon
Lyft
LYFT
+$50.4M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$41.3M
5
BAX icon
Baxter International
BAX
+$33.8M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$67.3M
2
HCA icon
HCA Healthcare
HCA
+$49.5M
3
THC icon
Tenet Healthcare
THC
+$48.5M
4
HOLX
Hologic
HOLX
+$45.6M
5
MTOR
MERITOR, Inc.
MTOR
+$29.4M

Sector Composition

Rank Sector Weight
1 Healthcare 69.28%
2 Technology 11.97%
3 Materials 5.01%
4 Consumer Discretionary 4.95%
5 Industrials 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
51
Microsoft
MSFT
$3.71T
$5.5M 0.13%
24,748
-28,916
-54% -$6.22M
DNB
52
DELISTED
Dun & Bradstreet
DNB
$4.98M 0.11%
+200,147
New +$5.34M
LAB icon
53
Standard BioTools
LAB
$314M
$4.86M 0.11%
809,369
– –
URI icon
54
United Rentals
URI
$72.4B
$2.97M 0.07%
12,804
-66,646
-84% -$14.1M
META icon
55
Meta Platforms (Facebook)
META
$1.51T
$2.62M 0.06%
+9,586
New +$2.63M
AMZN icon
56
Amazon
AMZN
$2.96T
$2.53M 0.06%
+15,560
New +$2.48M
EBAY icon
57
eBay
EBAY
$49.8B
– –
-289,767
Closed -$15.1M
BHVN
58
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-97,047
Closed -$6.31M
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Glenview Capital Management held 58 positions worth $4.36B, up 37% from $3.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management deployed $206M of net new capital in Q4 2020, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 184,461 shares worth $59.2M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 74% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Paramount Global Class B, an estimated $67.3M trimmed.

  • Glenview Capital Management's largest Q4 2020 buy was Elevance Health: 184,461 shares worth $59.2M.
  • Glenview Capital Management added most to Boston Scientific in Q4 2020, an estimated $59.8M increase.
  • Glenview Capital Management's biggest Q4 2020 reduction was Paramount Global Class B, cutting an estimated $67.3M.
  • Glenview Capital Management fully exited eBay in Q4 2020, selling an estimated $15.1M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $4.36B portfolio in Q4 2020.
  • Glenview Capital Management opened 13 new positions and closed 2 in Q4 2020.
  • Glenview Capital Management's portfolio value rose 37% quarter-over-quarter to $4.36B.

Based on Glenview Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.